Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and Female who aged 20 to under 65 at the time of informed consent. 2. Those who are susceptible to colds and influenza and are subject to suffered from upper respiratory tract infection within the last two years 3. Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who have a medical history of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder. 2. Those who have chronic diseases and use medicines constantly 3. Those with atopic dermatitis, bronchial asthma, or chronic bronchitis 4. Those who have hay fever and allergic rhinitis 5. Those who have digestive organ disease, surgical history affecting digestion and absorption of foods, or a disorder such as stenosis in the digestive tract. 6. Those who cannot stop eating foods which may activate immune functions 7. Those who have excessive smoking habits (21 or more cigarettes / day) 8. Those who have been vaccinated against influenza vaccine after October 2020, or who are planning to be vaccinated during the test period 9. Those with a food allergy 10. Those who consume alcohol excessively (alcohol equivalent 60g or more / day) 11. Those who cannot stop drinking for 2 days until the screening and each checkup 12. Those who are under treatment or have a history of drug/alcohol dependence 13. Those who work in shifts, such as those who work night shifts 14. Those who are planning to travel abroad during the test period 15. Those who are judged as unsuitable for the study based on the results of blood tests 16. Those who are positive for HBs antibody, HBs antigen or HCV antibody 17. Those who wish to become pregnant, breastfeeding, or during the test period 18. Those who donated blood over 200 mL in the past a month or over 400mL in the past three months from the date of informed consent 19. Those who are participating in other study that using food(s), or pharmaceutical(s), and cosmetic(s) now, or who have participated or are willing to participate in other studies within a month from the date of informed consent 20. Individuals who are judged as unsuitable for the study by the investigator for the other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major immune marker | — |
Secondary
| Measure | Time frame |
|---|---|
| Questionnaires to assess health condition | — |
Countries
Japan
Contacts
KSO Corporation Sales department